LSL Pharma Engages Red Cloud for Market Stability

LSL Pharma Group Inc (TSE:LSL) has released an update.

LSL Pharma Group Inc., a Canadian pharmaceutical company, has contracted Red Cloud Securities to enhance market stability and liquidity for its common shares on the TSX Venture Exchange. The agreement, which is subject to regulatory approval, involves Red Cloud providing these services for $5,000 per month, with the option for termination by either party given 30 days’ notice. While Red Cloud may hold a stake in LSL Pharma, the deal is strictly focused on improving the trading environment for LSL Pharma’s shares without any performance-based compensation.

For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.